Viewing Study NCT03342300


Ignite Creation Date: 2025-12-26 @ 12:14 PM
Ignite Modification Date: 2026-01-13 @ 12:09 PM
Study NCT ID: NCT03342300
Status: WITHDRAWN
Last Update Posted: 2020-05-19
First Post: 2017-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Sponsor: Peking University People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module